Teva fails to invalidate Vigamox

U.S. District Judge Sue L. Robinson (Delaware) ruled last week that Israel’s Teva Pharmaceuticals infringed the patents for Vigamox and failed to prove the patents invalid. Vigamox is used to treat eye infections and is made by Nestle’s Alcon unit. Teva challenged the validity of the patent in 2006. If it had been successful, Teva would have been able to launch its own competing product in 2014, six years before the expiration of the Vigamox patent.



Categories: News, Patents, pharmaceuticals, Teva, US

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: